Gene · 55902
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
From metabolites to chromatin: ACSS2-driven acetyl-CoA fuels H3K27ac chromatin remodeling in HBV-associated HCC: Editorial on "Acetyl-coenzyme A synthetase 2-mediated acetyl-coenzyme A accumulation promotes mitophagy and tumor growth via increased H3K27ac in hepatitis B virus-related hepatocellular carcinoma". | Clin Mol Hepatol | 2026 | 41622631 | PubTator, text mining | PubMed |
| ¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis. | Sci Rep | 2026 | 41617901 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
| Role of Acyl-CoA Synthetase (ACS) from Dietzia aurantiaca Strain J3 and Glutathione (GSH) in Fluorotelomer Biotransformation. | Environ Sci Technol | 2026 | 41589564 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| Mitochondrial acetyl-CoA reprogramming by the SIRT3-ACSS2-OPA1 axis confers resistance to ferroptosis in Parkinson's disease. | Redox Biol | 2026 | 41570770 | PubTator, text mining | PubMed |
| Histone and non-histone (de)acetylation impact on the blood-brain barrier. | Fluids Barriers CNS | 2026 | 41566325 | PubTator, text mining | PubMed |
| The UFL1-AKT positive feedback loop promotes breast cancer progression by enhancing lipid synthesis. | Nat Commun | 2026 | 41559041 | PubTator, text mining | PubMed |
| Crotonate suppresses breast cancer metastasis and promotes immunotherapy response by inducing ACSS2-mediated EZH2-K348 crotonylation. | Sci Adv | 2026 | 41544165 | PubTator, text mining | PubMed |
| Narciclasine Alleviates Endothelial Inflammation and Atherosclerosis Initiation by Inhibiting Histone Lactylation-Mediated NF-κB Activation. | Inflammation | 2026 | 41543766 | PubTator, text mining | PubMed |
| Fueling Disease: ACSS2 in Obesity-Associated Metabolic Disorders and Cancer Progression. | Obes Rev | 2026 | 41540671 | PubTator, text mining | PubMed |
| Acetyl-CoA-producing enzymes are a targetable metabolic entry point to MASLD and liver fibrosis. | Cell Metab | 2026 | 41500201 | PubTator, text mining | PubMed |
| Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH. | Cell Metab | 2026 | 41500198 | PubTator, text mining | PubMed |
| Crotonylation and the Risk of Head and Neck Cancer: Insights from a Two-Sample Mendelian Randomization Study. | Int Dent J | 2026 | 41447823 | PubTator, text mining | PubMed |
| Acetyl-coenzyme A synthetase 2-mediated acetyl-coenzyme A accumulation promotes mitophagy and tumor growth via increased H3K27ac in hepatitis B virus-related hepatocellular carcinoma. | Clin Mol Hepatol | 2026 | 41414763 | PubTator, text mining | PubMed |
| Microbial acetyl-CoA synthesis as an emerging metabolic and regulatory hub in plant-microbe interactions. | Microbiol Res | 2026 | 41365070 | PubTator, text mining | PubMed |
| Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy. | Nature | 2026 | 41225001 | PubTator, text mining | PubMed |
| Luteolin protects against alcoholic liver injury by restoring NRF2 stability to suppress ACSS2 nuclear accumulation. | NPJ Sci Food | 2025 | 41249207 | PubTator, text mining | PubMed |
| PGC-1α regulates lipid accumulation by coordinating fatty acid synthesis and oxidation in goose fatty liver. | Poult Sci | 2025 | 41205434 | PubTator, text mining | PubMed |
| USP2-mediated PPARγ stabilization promotes hepatocellular carcinoma progression and M2 macrophage polarization via oleic acid. | J Immunother Cancer | 2025 | 41193183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55902/papers?page=5